Skip to main content

Advertisement

SpringerLink
Log in

The impact of sentinel lymph node biopsy in patients with a core biopsy diagnosis of ductal carcinoma in situ

  • Original Article
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Background

When ductal carcinoma in situ (DCIS) is found on core biopsy, histological underestimation can occur due to sampling error. When an invasive cancer is subsequently found, another operation is required for nodal staging. Sentinel lymph node biopsy (SLNB) enables nodal staging at the same operation. We examine the value of SLNB in patients with a preoperative diagnosis of DCIS focusing on the need for reoperation.

Methods

Patients with a preoperative core biopsy of DCIS underwent SLNB at the time of definitive surgery. The results of SLNB in relation to histological upstaging were analyzed.

Results

One hundred and seven patients with a core biopsy diagnosis of DCIS underwent simultaneous SLNB at the time of definitive surgery. SLNB was successful in 103 patients (96.3%) and 12 (11.7%) had SLN metastases. Thirty-two patients (29.9%) had histological upstaging and SLN was positive in nine (28.1%). Seventy-five patients had “pure DCIS” but three (4%) had SLN metastases. The presence of a palpable mass and radiological mass lesion were associated with histological upstaging. If SLNB were not performed, 32 patients (29.9%) with upstaging would require another surgery to stage the axilla. In the present series, 84% of these patients had appropriate axillary staging without the need for a second operation.

Conclusion

Underestimation of invasive disease was frequent on core biopsy. Performing SLNB during definitive surgery allowed correct nodal staging in a single operation. SLN metastasis was rare in patients with “pure DCIS” on final pathology. However, additional systemic treatment may be indicated for patients with SLN micrometastases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Yen T, Hunt KK, Ross MI, et al. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg. 2005;200:516–26.

    Article  PubMed  Google Scholar 

  2. Pendas S, Dauway E, Giuliano R, Ku NN, Cox CE, Reintgen DS. Sentinel node biopsy in DCIS patients. Ann Surg Oncol. 2000;7:15–20.

    Article  CAS  PubMed  Google Scholar 

  3. Pendas S, Jakub J, Giuliano R, Gardner M, Swor GB, Reintgen DS. The role of sentinel lymph node biopsy in patients with ductal carcinoma in situ or with locally advanced breast cancer receiving neoadjuvant chemotherapy. Cancer Control. 2004;11(4):231–5.

    PubMed  Google Scholar 

  4. Hung WK, Chan CM, Ying M, Chong SF, Mak KL, Yip AW. Randomized clinical trial comparing blue dye with combined dye and isotope for sentinel lymph node biopsy in breast cancer. Br J Surg. 2005;92(12):1494–7.

    Article  CAS  PubMed  Google Scholar 

  5. Barros AC, Barros MA, Andrade FE, et al. Combined radioguided nonpalpable lesion localization and sentinel lymph node biopsy for early breast carcinoma. Ann Surg Oncol. 2007;14(4):1472–7.

    Article  PubMed  Google Scholar 

  6. Klauber-DeMore N, Tan LK, Liberman L, et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma in situ and ductal carcinoma-in situ with microinvasion? Ann Surg Oncol. 2000;7:636–42.

    Article  CAS  PubMed  Google Scholar 

  7. Cox CE, Nguyen K, Gray RJ, et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg. 2001;67:513–9.

    CAS  PubMed  Google Scholar 

  8. Intra M, Veronesi P, Mazzarol G, et al. Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg. 2003;138(3):309–13.

    Article  PubMed  Google Scholar 

  9. Wilkie C, White L, Dupont E, Cantor A, Cox CE. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. Am J Surg. 2005;190:563–6.

    Article  PubMed  Google Scholar 

  10. Zavagno G, Carcoforo P, Marconato R, et al. Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. BMC Cancer. 2005;5:28.

    Article  PubMed  Google Scholar 

  11. Camp R, Feezor R, Kasraeian A, et al. Sentinel lymph node biopsy for ductal carcinoma in situ: an evolving approach at the University of Florida. Breast J. 2005;11(6):394–7.

    Article  PubMed  Google Scholar 

  12. Mittendorf EA, Arciero CA, Gutchell V, Hooke J, Shriver CD. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. Curr Surg. 2005;62(2):253–7.

    Article  PubMed  Google Scholar 

  13. Tan JC, McCready DR, Easson AM, Leong WL. Role of sentinel lymph node biopsy in ductal carcinoma-in situ treated by mastectomy. Ann Surg Oncol. 2007;14(2):638–45.

    Article  PubMed  Google Scholar 

  14. Ansari B, Ogston SA, Purdie CA, Adamson DJ, Brown DC, Thompson AM. Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast. Br J Surg. 2008;95(5):547–54.

    Article  CAS  PubMed  Google Scholar 

  15. Goyal A, Douglas-Jones A, Monypenny I, Sweetland H, Stevens G, Mansel RE. Is there a role of SLNB in DCIS? Analysis of 587 cases. Breast Cancer Res Treat. 2006;98(3):311–4.

    Article  PubMed  Google Scholar 

  16. Huo L, Sneige N, Hunt KK, Albarracin CT, Lopez A, Resetkova E. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ. Cancer. 2006;107(8):1760–8.

    Article  PubMed  Google Scholar 

  17. Meijnen P, Oldenburg HSA, Loo CE, Nieweg OE, Peterse JL, Rutgers EJT. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy. Br J Surg. 2007;94:952–6.

    Article  CAS  PubMed  Google Scholar 

  18. Fleissig A, Fallowfield LJ, Langridge CI, et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomized trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat. 2006;95:279–93.

    Article  PubMed  Google Scholar 

  19. Lagios MD, Silverstein MJ. Sentinel node biopsy for patients with DCIS: a dangerous and unwarranted direction. Ann Surg Oncol. 2001;8:275–7.

    Article  CAS  PubMed  Google Scholar 

  20. Moore KH, Thaler HT, Tan LK, Borgen PI, Cody HS. Immunohistochemically detected tumor cells in the sentinel lymph nodes of patients with breast carcinoma: biologic metastasis or procedural artifact? Cancer. 2004;100:929–34.

    Article  PubMed  Google Scholar 

  21. Carter BA, Jensen RA, Simpson JF, Page DL. Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol. 2000;113:259–65.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Kwong Wah Hospital, 25 Waterloo Road, Kowloon, Hong Kong, China

    Wai Ka Hung, Marcus Ying & Miranda Chan

  2. Department of Pathology, Kwong Wah Hospital, Kowloon, Hong Kong, China

    Kong Ling Mak

  3. Department of Diagnostic Radiology, Kwong Wah Hospital, Kowloon, Hong Kong, China

    Lap Kin Chan

Authors
  1. Wai Ka Hung
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marcus Ying
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Miranda Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kong Ling Mak
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lap Kin Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wai Ka Hung.

About this article

Cite this article

Hung, W.K., Ying, M., Chan, M. et al. The impact of sentinel lymph node biopsy in patients with a core biopsy diagnosis of ductal carcinoma in situ. Breast Cancer 17, 276–280 (2010). https://doi.org/10.1007/s12282-009-0164-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12282-009-0164-2

Keywords

Search

Navigation